Blood transfusion optimization

The Uniformed Services University of the Health Sciences awarded The Geneva Foundation a $2.298 million cooperative agreement on January 1, 2026, under the Uniformed Services University Medical Research Projects program (CFDA 12.750) to support Blood Transfusion Optimization research through December 31, 2028.

The award funds research and development activities to optimize blood transfusion protocols and clinical practices for military medical readiness. Work is performed in Westlake, Maryland. The Geneva Foundation, a 501(c)(3) nonprofit research organization headquartered in Tacoma, Washington, serves as the recipient and conducts military medical research across combat casualty care, clinical support services, and biomedical innovation for defense and health agencies. The foundation frequently sub-awards to academic medical centers and research universities; The Henry M. Jackson Foundation for the Advancement of Military Medicine is a known sub-recipient on Geneva's blood transfusion optimization and related clinical outcomes research programs. The period of performance runs three years from January 1, 2026, to December 31, 2028, with $2.298 million obligated at award.